Search Result "GluN2B antagonists"
GluN2B/N-methyl-D-aspartate Receptor Antagonists: Advances in Design, Synthesis, and Pharmacological Evaluation Studies
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 20 Issue: 9 Year: 2021 Page: 822-862
Author(s): Vinod Ugale,Ashish Dhote,Rushikesh Narwade,Saurabh Khadse,P. Narayana Reddy,Atul Shirkhedkar
Molecular Modeling of Benzimidazole Derivatives: A Promising Series of GluN2B Selective NMDA Receptor Antagonists
Journal: Current Drug Therapy
Volume: 13 Issue: 2 Year: 2018 Page: 152-161
Author(s): Marcos Vinicius Santana,Helena Carla Castro,Paula Alvarez Abreu
Group I mGluR Induced LTD of NMDAR-synaptic Transmission at the Schaffer Collateral but not Temperoammonic Input to CA1
Journal: Current Neuropharmacology
Volume: 14 Issue: 5 Year: 2016 Page: 435-440
Author(s): Stephen Fitzjohn,Zafar Bashir,Paul Farrow
NMDA Receptor Antagonists: Repositioning of Memantine as a Multitargeting Agent for Alzheimer's Therapy
Journal: Current Pharmaceutical Design
Volume: 25 Issue: 33 Year: 2019 Page: 3506-3518
Author(s): Md. Tanvir Kabir,Mohammad A. Sufian,Md. Sahab Uddin,Mst. Marium Begum,Shammi Akhter,Ariful Islam,Bijo Mathew,Md. Siddiqul Islam,Md. Shah Amran,Ghulam Md. Ashraf
Discovery of Multi-functional Lead Compounds Originating fromTraditional Chinese Medicine for Developing Anti-depressive Agents viaVirtual Screening
Journal: Letters in Drug Design & Discovery
Volume: 21 Issue: 10 Year: 2024 Page: 1745-1754
Author(s):
N-Methyl-D-Aspartate (NMDA) Receptor Antagonists and theirPharmacological Implication: A Medicinal Chemistry-orientedPerspective Outline
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 29 Year: 2024 Page: 4725-4744
Author(s):
Amyloid-Beta Peptide 1-42 Causes Microtubule Deregulation through N-methyl-D-aspartate Receptors in Mature Hippocampal Cultures
Journal: Current Alzheimer Research
Volume: 9 Issue: 7 Year: 2012 Page: 844-856
Author(s): Sandra I. Mota,Ildete L. Ferreira,Claudia Pereira,Catarina R. Oliveira,A. Cristina Rego
NMDA Receptor as a Molecular Target for Central Nervous System Disorders: The Advances and Contributions of Molecular Modeling
Ebook: Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Volume: 5 Year: 2017
Author(s): Marcos Vinicius Santana,Helena Carla Castro,Paula Alvarez Abreu
Doi: 10.2174/9781681085852117050008
Beyond Ketamine: New Approaches to the Development of Safer Antidepressants
Journal: Current Neuropharmacology
Volume: 15 Issue: 7 Year: 2017 Page: 963-976
Author(s): Shigeyuki Chaki
Specific Roles of NMDA Receptor Subunits in Mental Disorders
Journal: Current Molecular Medicine
Volume: 15 Issue: 3 Year: 2015 Page: 193-205
Author(s): H. Yamamoto,Y. Hagino,S. Kasai,K. Ikeda